On June 5, the advertising magnate Maurice Saatchi reintroduced the Medical Innovation Bill into the UK House of Lords. Anguished and angered by the lack of effective treatment for his wife, who died from ovarian cancer 3 years ago, the Bill aims to protect doctors from litigation should they choose different treatment approaches when established treatment has failed. The Bill does not alter UK law concerning patients' consent, nor the current common law of medical negligence (the Bolam and Bolitho test). (Editorial)